Metabolic syndrome and population attributable risk among HIV/AIDS patients: Comparison between NCEP-ATPIII, IDF and AHA/NHLBI definitions

AIDS Research and Therapy

Volumn 9, Issue , 2012, Pages

  Alencastro, Paulo R ^a,b   Wolff, Fernando H ^b,c   Oliveira, Renato R ^a   Ikeda, Maria Letícia R ^a,c   Barcellos, Nêmora T ^a,c   Brandão, Ajácio B M ^b   Fuchs, Sandra C ^b,c  

^a Hosp Sanat Partenon   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

AHA NHLBI; HIV AIDS; IDF; Metabolic syndrome; NCEP ATPIII; Population attributable risk; Waist circumference

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIRETROVIRUS AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD EXAMINATION; BLOOD PRESSURE; BRAZIL; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE REGISTRY; FEMALE; GLUCOSE BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; WAIST CIRCUMFERENCE;

EID: 84866933470     PISSN: None     EISSN: 17426405     Source Type: Journal    
DOI: 10.1186/1742-6405-9-29     Document Type: Article

References (40)

1. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005, 28:1769-1778. 10.2337/diacare.28.7.1769, 15983333.
2. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007, 30:8-13. 10.2337/dc06-1414, 17192325.
3. Hall WD, Watkins LO, Wright JT, Wenger NK, Kumanyika SK, Gavin JR, Ferdinand KC, Watson K, Clark LT, Flack JM, Reed JW, Horton EW, Saunders E, . African-American Lipid and Cardiovascular Council The metabolic syndrome: recognition and management. Dis Manag 2006, 9:16-33. 10.1089/dis.2006.9.16, 16466339, African-American Lipid and Cardiovascular Council.
4. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366:1059-1062. 10.1016/S0140-6736(05)67402-8, 16182882.
5. Adult Treatment Panel III Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Publication 01-3670 2002, 1-50. National Institutes of Health, Bethesda,MD, NIH Publication No. 02-5215, Adult Treatment Panel III.
6. Adult Treatment Panel III Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421. Adult Treatment Panel III.
7. The International Diabetes Federation The IDF consensus worldwide definition of metabolic syndrome [article online] 2005, In: http://www.idf.org/webdata/docs/MetS_def_update2006.pdf, The International Diabetes Federation.
8. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433-438. 10.1161/01.CIR.0000111245.75752.C6, 14744958.
9. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F, . American Heart Association; National Heart, Lung, and Blood Institute Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752. 10.1161/CIRCULATIONAHA.105.169404, 16157765, American Heart Association; National Heart, Lung, and Blood Institute.
10. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, . International Diabetes Federation TaskForce on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; InternationalAtherosclerosis Society; International Association for the Study of Obesity Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645. 10.1161/CIRCULATIONAHA.109.192644, 19805654, International Diabetes Federation TaskForce on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; InternationalAtherosclerosis Society; International Association for the Study of Obesity.
11. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359. 10.1001/jama.287.3.356, 11790215.
12. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care 2004, 27:2444-2449. 10.2337/diacare.27.10.2444, 15451914.
13. Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia. Diabetes Care 2007, 30:113-119. 10.2337/dc06-1075, 17192343.
14. Bonfanti P, Giannattasio C, Ricci E, Facchetti R, Rosella E, Franzetti M, Cordier L, Pusterla L, Bombelli M, Sega R, Quirino T, Mancia G. HIV and metabolic syndrome: a comparison with the general population. J Acquir Immune Defic Syndr 2007, 45:426-431. 10.1097/QAI.0b013e318074ef83, 17514013.
15. Grinspoon SK. Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus. Am J Med 2005, 118(Suppl 2):23S-28S.
16. Nolan D. Metabolic complications associated with HIV protease inhibitor therapy. Drugs 2003, 63:2555-2574. 10.2165/00003495-200363230-00001, 14636077.
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, . National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood PressureEducation Program Coordinating Committee The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572. 10.1001/jama.289.19.2560, 12748199, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood PressureEducation Program Coordinating Committee.
18. SBC I Diretriz Brasileira de Diagnóstico e Tratamento da Síndrome Metabólica. Arq Bras Cardiol 2005, 84(1):S1-S28. SBC.
19. O'Brien E, Mee F, Atkins N, Thomas M. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press Monit 1996, 1:55-61.
20. World Health Organization Physical status: the use and interpretation of anthropometry. Report of the WHO Expert Committee. World Health Organ Tech Rep Ser 1995, 854:1-452. World Health Organization.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
22. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973, 19:476-482.
23. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969, 22:158-161. 10.1136/jcp.22.2.158, 474026, 5776547.
24. PN/DST/AIDS Ministério da Saúde do Brasil - Programa Nacional de Doenças Sexualmente Transmissíveis / AIDS - Rede Nacional de Labortórios de CD4+/CD8+ e de Carga Viral 2009, In: http://www.aids.gov.br/data/, PN/DST/AIDS.
25. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Dubrow R, Rotterdam H, West AB, Blaser M, Blot WJ, Gail MH, Fraumeni JF. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003, 95:1404-1413. 10.1093/jnci/djg047, 13130116.
26. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, . INTERHEART Study Investigators Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952. 10.1016/S0140-6736(04)17018-9, 15364185, INTERHEART Study Investigators.
27. Levine B. What does the population attributable fraction mean?. Prev Chronic Dis 2007, 4:A14. 1832135, 17173722.
28. Grunfeld C, Kotler DP, Hamadeh R, Tierney A, Wang J, Pierson RN. Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1989, 86:27-31.
29. Meenan J, Mooney E, Mosquita N, Johnson AH, Collins P, Feely J, Mulcahy FM. The impact of HIV disease progression on serum lipoproteins. AIDS 1992, 6:1551-1552. 10.1097/00002030-199212000-00026, 1492943.
30. Jacobson DL, Tang AM, Spiegelman D, Thomas AM, Skinner S, Gorbach SL, Wanke C. Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey). J Acquir Immune Defic Syndr 2006, 43:458-466. 10.1097/01.qai.0000243093.34652.41, 16980905.
31. Squillace N, Zona S, Stentarelli C, Orlando G, Beghetto B, Nardini G, Esposito R, Guaraldi G. Detectable HIV Viral Load Is Associated With Metabolic Syndrome. J Acquir Immune Defic Syndr 2009, 52:459-464. 10.1097/QAI.0b013e3181b93a23, 19779308.
32. Hansen BR, Petersen J, Haugaard SB, Madsbad S, Obel N, Suzuki Y, Andersen O. The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy. HIV Med 2009, 10:378-387. 10.1111/j.1468-1293.2009.00697.x, 19490178.
33. Bonfanti P, Ricci E, de Socio G, Zeme D, Carradori S, Penco G, Parruti G, Grosso C, Madeddu G, Vichi F, Bini T, Martinelli C, Melzi S, Quirino T, . CISAI StudyGroup Metabolic syndrome: a real threat for HIV-positive patients?: Results from the SIMONE study. J Acquir Immune Defic Syndr 2006, 42:128-131. 10.1097/01.qai.0000219775.20174.2d, 16763502, CISAI StudyGroup.
34. Gus M, Cichelero FT, Moreira CM, Escobar GF, Moreira LB, Wiehe M, Fuchs SC, Fuchs FD. Waist circumference cut-off values to predict the incidence of hypertension: an estimation from a Brazilian population-based cohort. Nutr Metab Cardiovasc Dis 2009, 19:15-19. 10.1016/j.numecd.2008.03.007, 18674892.
35. Donato GB, Fuchs SC, Oppermann K, Bastos C, Spritzer PM. Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio. Menopause 2006, 13:280-285. 10.1097/01.gme.0000177907.32634.ae, 16645541.
36. Athyros VG, Ganotakis ES, Tziomalos K, Papageorgiou AA, Anagnostis P, Griva T, Kargiotis K, Mitsiou EK, Karagiannis A, Mikhailidis DP. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Curr Med Res Opin 2010, 26:713-719. 10.1185/03007991003590597, 20078335.
37. Panagiotakos DB, Pitsavos C, Das UN, Skoumas Y, Stefanadis C. The implications of anthropometric, inflammatory and glycaemic control indices in the epidemiology of the metabolic syndrome given by different definitions: a classification analysis. Diabetes Obes Metab 2007, 9:660-668. 10.1111/j.1463-1326.2006.00640.x, 17697058.
38. Ascaso JF, Romero P, Real JT, Lorente RI, Martinez-Valls J, Carmena R. Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. Eur J Intern Med 2003, 14:101-106. 10.1016/S0953-6205(03)00022-0, 12719027.
39. Bernal E, Masia M, Padilla S, Martin-Hidalgo A, Gutierrez F. Prevalence and characteristics of metabolic syndrome among HIV-infected patients from a Mediterranean cohort]. Med Clin (Barc) 2007, 128:172-175. quiz 171 p following 200.
40. Jerico C, Knobel H, Montero M, Ordonez-Llanos J, Guelar A, Gimeno JL, Saballs P, López-Colomés JL, Pedro-Botet J. Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors. Diabetes Care 2005, 28:132-137. 10.2337/diacare.28.1.132, 15616246.